Go to Top

Cell-based Gene Therapy for Premature Ovarian Failure, Mrs. Elizabeth from Australia

Name: Mrs. Elizabeth
Age: 44
Gender: Female
Nationality: Australia
Diagnosis: Premature Ovarian Failure
Therapy: Cell-based Gene Therapy (HGF and adipose-derived stem cells)

Conditions before Cell-Based Gene Therapy for Premature Ovarian Failure

Mrs. Elizabeth is a 44 years old patient from Australia. She is a successful businesswoman and dedicated mother to two lovely daughters. After giving birth to her daughters during her thirties, Mrs. Elizabeth underwent two abortions. When she was 40, she started to experience some disorders, including bad temper, night sweats and irregular periods. After being diagnosed at local hospital, Mrs. Elizabeth’s medical report showed follicle stimulating hormone of 34~42. She was later diagnosed as having premature ovarian failure. Under the recommendation of her doctor, she accepted estrogen replacement therapy, with only minor results. Giving consideration to the long term medical solution, she sought high tech medical therapy and finally decided to undergo cell-based gene therapy.

Therapy and Procedure

Cell-based gene therapy (HGF and adipose-derived stem cells): 4 IV injections

Conditions after Cell-Based Gene Therapy for Premature Ovarian Failure

After receiving cell-based gene therapy, Mrs. Elizabeth has participated in Tai Chi classes. Her overall condition including sleep condition has improved. Her skin looks much younger than before. Eight months after being discharged from hospital, Mrs. Elizabeth wrote in the letter:”I feel young again. With the energy I have, I can accomplish much more, not just in my career but also with my family…”

Google+ Paste your AdWords Remarketing code here